Torres, VE, Ahn, C, Barten, TRM, Brosnahan, G, Cadnapaphornchai, MA, Chapman, AB, Cornec-Le Gall, E, Drenth, JPH, Gansevoort, RT, Harris, PC, Harris, T, Horie, S, Liebau, MC, Liew, M, Mallett, AJ, Mei, CL, Mekahli, D, Odland, D, Ong, ACM, Onuchic, LF, Pei, YPC, Perrone, RD, Rangan, GK, Rayner, B, Torra, R, Balk, EM, Gordon, CE, Earley, A, Mustafa, RA, Devuyst, O. KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary. KIDNEY INTERNATIONAL. 2025; 107(2)DOI:10.1016/j.kint.2024.07.010. PMID:39848746. IF:12.600(Q1/1D).

Brand, E, Linhart, A, Deegan, P, Jurcut, R, Pisani, A, Torra, R, Feldt-Rasmussen, U. Clinical management of female patients with Fabry disease based on expert consensus. Orphanet Journal of Rare Diseases. 2025; 20(1)DOI:10.1186/s13023-024-03500-7. PMID:39773286. IF:3.500(Q2/4D).

Hughes, DA, Sunder-Plassmann, G, Jovanovic, A, Brand, E, West, ML, Bichet, DG, Pisani, A, Nowak, A, Torra, R, Khan, A, Azevedo, O, Lehman, A, Linhart, A, Rutecki, J, Giuliano, JD, Krusinska, E, Nordbeck, P. Renal and multisystem effectiveness of 3.9 years of migalastat in a global real-world cohort: Results from the followME Fabry Pathfinders registry. JOURNAL OF INHERITED METABOLIC DISEASE. 2025; 48(1)DOI:10.1002/jimd.12771. PMID:39031114. IF:3.800(Q2/3D).

Riera-Escamilla, A, Arafa, MM, Farnetani, G, Xavier, MJ, Oud, MS, Majzoub, AA, Ramos, L, Abrardo, C, Spinelli, M, Moreno-Mendoza, D, Defazio, G, Ars, E, Pybus, M, Curbelo, JRS, Elbardisi, HT, Nawaz, S, Syed, N, Ruiz-Castané, E, van der Heijden, GW, Fakhro, KA, Veltman, JA, Krausz, C. Genetic determinants of testicular sperm extraction outcomes: insights from a large multicentre study of men with non-obstructive azoospermia. Human Reproduction Open. 2025; 2025(3)DOI:10.1093/hropen/hoaf049. PMID:40896145. IF:11.100(Q1/1D).